The proteome of a new Bacillus thuringiensis subsp. kurstaki strain, 4.0718, from the middle vegetative (T 1 ), early sporulation (T 2 ), and late sporulation (T 3 ) phases was analyzed using an integrated liquid chromatography (LC)-based protein identification system. The system comprised two-dimensional (2D) LC coupled with nanoscale electrospray ionization (ESI) tandem mass spectrometry (MS/MS) on a high-resolution hybrid mass spectrometer with an automated data analysis system. After deletion of redundant proteins from the different batches and B. thuringiensis subspecies, 918, 703, and 778 proteins were identified in the respective three phases. Their molecular masses ranged from 4.6 Da to 477.4 Da, and their isoelectric points ranged from 4.01 to 11.84. Function clustering revealed that most of the proteins in the three phases were functional metabolic proteins, followed by proteins participating in cell processes. Small molecular and macromolecular metabolic proteins were further classified according to the Kyoto Encyclopedia of Genes and Genome and BioCyc metabolic pathway database. Three protoxins (Cry2Aa, Cry1Aa, and Cry1Ac) as well as a series of potential intracellular active factors were detected. Many significant proteins related to spore and crystal formation, including sporulation proteins, help proteins, chaperones, and so on, were identified. The expression patterns of two identified proteins, CotJc and glutamine synthetase, were validated by Western blot analysis, which further confirmed the MS results. This study is the first to use shotgun technology to research the proteome of B. thuringiensis. Valuable experimental data are provided regarding the methodology of analyzing the B. thuringiensis proteome (which can be used to produce insecticidal crystal proteins) and have been added to the related protein database.
Bacillus thuringiensis is characterized by the production of a parasporal body during sporulation, which contains one or more Cry and/or Cyt proteins (also known as ␦-endotoxins) in crystalline form (17, 42). Many B. thuringiensis subspecies are used as bacterial insecticides and sources of genes for the recombinant bacteria and B. thuringiensis strains applied for insecticidal products (5, 31). Since the 1980s, substantial progress has been made in the development and production of new genetically engineered B. thuringiensis insecticides, especially in the transformation of insecticidal crystal proteins (ICPs), due to the ever-increasing research on the B. thuringiensis protein production mechanisms and genetic structure. For B. thuringiensis, many researchers have found great difficulty in achieving marked improvements in ICP only by traditional fermentation and mutagenesis treatment, which hinders the practical applications of B. thuringiensis. The challenge is probably rooted in the fact that except for the closely synergistic effect with spore formation (2), ICPs are synthesized via multiple intracellular reactions, which are further complicated by various factors, including c...